Mereo BioPharma Group PLC (United States) is listed on the Nasdaq and has a market capitalization of $50.11 Millions, with shareholders equity totaling $34.05 Millions.
The company employs approximately 38 people and operates in the Services sector, within the Commercial Services industry.
Over the past 12 months, Mereo BioPharma Group PLC reported $500.00 Thousand in revenue, generating net income of $-35.71 Millions.
Key financial metrics include a P/E ratio of -1.40, a price-to-book (P/B) ratio of 1.47, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker MREO.